# Implantation or Injectable Dosage Form New Animal Drugs; Spectinomycin Sulfate
> **Food and Drug Administration** · Final rule. · Published 2007-06-06 · Effective 2007-06-06 · 72 FR 31177
## Document
- **Document number:** E7-10801
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 72 FR 31177
- **CFR reference:** 21 CFR 522
- **Publication date:** 2007-06-06
- **Effective date:** 2007-06-06
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a supplemental new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Div. of Pfizer, Inc. The supplemental NADA provides for revising nomenclature for two bovine respiratory pathogens on labeling for spectinomycin sulfate injectable solution.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2007/06/06/E7-10801/implantation-or-injectable-dosage-form-new-animal-drugs-spectinomycin-sulfate)
---
*AI Analytics · CC0 1.0*